79,96 €
1,46 %
L&S, 30. Juni, 22:54 Uhr. Geschlossen.
ISIN
US0028241000
Symbol
ABT
Berichte

Abbott Laboratories Aktie News

Neutral
Market Watch
vor einem Tag
This relationship between inflation and value stocks' outperformance is often overlooked. Many investment experts mistakenly believe that a strong economy, not inflation, is the key to value stocks beating growth stocks.
Positiv
Reuters
vor 2 Tagen
The U.S. Justice ​Department closed a ‌criminal probe into Abbott ​Laboratories over ​how it managed a ⁠baby ​formula facility where ​potentially deadly bacteria were discovered and ​suspected ​of causing infant deaths, ‌and ⁠instead opted for civil penalties, the ​Wall ​Street ⁠Journal reported on ​Sunday, citing ​people ⁠familiar with the matter.
Negativ
WSJ
vor 2 Tagen
WASHINGTON—The Justice Department spent years investigating Abbott Laboratories ABT 0.94%increase; up pointing triangle over how it managed a baby formula facility where potentially deadly bacteria was discovered and suspected of causing infant deaths, worsening a national shortage.
Positiv
Seeking Alpha
vor 3 Tagen
Dividend Aristocrats rebounded in June and are now outperforming SPY YTD with a 9.61% return versus SPY's 6.91%. CAT leads 2026 performance at +76.98%, with 46 Aristocrats now ahead of SPY and 39 posting double-digit total returns. Recent dividend increases averaged 4.09%, slightly below the 2025 average, with 2026's average dividend growth rate at 3.97%.
Neutral
PRNewsWire
vor 6 Tagen
ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer's Diagnosis at Global Scale CARLSBAD, Calif., June 24, 2026 /PRNewswire/ -- ALZpath Inc.,  the leader in blood test-based diagnostic solutions for Alzheimer's disease, today announced a licensing agreement with Abbott (NYSE: ABT), a global healthcare leader, to incorporate ALZpath's proprietary phosphoryl...
Positiv
Reuters
vor 6 Tagen
ALZpath said on Wednesday it had signed a global licensing agreement with Abbott Laboratories to help advance blood-based ​testing for Alzheimer's disease, as companies race to offer ‌easier-to-use diagnostic options for the brain-wasting disease.
Negativ
Reuters
vor 7 Tagen
A Missouri appeals court on Monday ​declined to send Abbott Laboratories' appeal of a $495 million verdict in a case claiming the company's specialized formula ‌for premature infants caused an Illinois girl to develop a dangerous bowel disease to the Missouri Supreme Court.
Neutral
PRNewsWire
vor 8 Tagen
Despite optimism about parenthood, unrealistic online portrayals are adding pressure for today's young parents Through the new "Love Without Measure" initiative, Similac is standing with parents in promoting more authentic portrayals of parenthood and pushing back on comparison culture ABBOTT PARK, Ill., June 22, 2026 /PRNewswire/ -- Parenthood is widely anticipated as one of life's most fulfil...

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen